Clinicopathologic significance of synchronous and metachronous adenomas in colorectal cancer

Mark Mattar, Paul Frankel, Donald David, Kevin O. Clarke, David Z.J. Chu, Chungling Jiang, Yun Yen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: Colorectal cancers (CRCs) evolve from a multiple-step tumorigenesis and, morphologically, are characterized by adenoma. Colorectal cancers with adenomas have distinct clinical features, including reports of improved survival. It is hypothesized that this survival advantage is related to biologic differences in CRC with adenomas rather than earlier diagnosis or earlier stage of disease presentation. Patients and Methods: A retrospective chart review of 569 patients treated from 1983 through 2002 was conducted. Data on age, sex, and survival; CRC stage, location, and recurrence; adenoma number, size, histology, and location; and colonoscopy history were analyzed. Results: The mean patient age was 62 years (range, 17-90 years), and 54% of patients were men. The majority of CRCs were left-sided (67%). The American Joint Committee on Cancer stage distribution was 0/I (12%), II (21%), III (34%), and IV (33%). Colorectal cancer with synchronous adenoma was seen in 33% of cases; overall, CRC with adenoma comprised 42% of cases. The event-free survival and overall survival favored CRC with adenoma. After adjusting for age, disease stage, sex, and total number of colonoscopic examinations, the relative risk for an event was 1.51 (P < 0.003) for patients without adenomas versus those with adenomas. Conclusion: Colorectal cancer with adenoma represents a distinct population of patients with CRC. The apparent association seems to confer a survival advantage that is not based on age, sex, or disease stage. The survival benefit, although slightly less dramatic, remained significant even when controlled for the number of colonoscopies.

Original languageEnglish
Pages (from-to)274-278
Number of pages5
JournalClinical Colorectal Cancer
Volume5
Issue number4
DOIs
Publication statusPublished - Jan 1 2005
Externally publishedYes

Fingerprint

Adenoma
Colorectal Neoplasms
Survival
Colonoscopy
Disease-Free Survival
Early Diagnosis
Histology
Carcinogenesis
History
Recurrence

Keywords

  • Colonoscopy
  • Disease staging
  • Event-free survival
  • Familial adenopolyposis
  • Microsatellite instability

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Clinicopathologic significance of synchronous and metachronous adenomas in colorectal cancer. / Mattar, Mark; Frankel, Paul; David, Donald; Clarke, Kevin O.; Chu, David Z.J.; Jiang, Chungling; Yen, Yun.

In: Clinical Colorectal Cancer, Vol. 5, No. 4, 01.01.2005, p. 274-278.

Research output: Contribution to journalArticle

Mattar, Mark ; Frankel, Paul ; David, Donald ; Clarke, Kevin O. ; Chu, David Z.J. ; Jiang, Chungling ; Yen, Yun. / Clinicopathologic significance of synchronous and metachronous adenomas in colorectal cancer. In: Clinical Colorectal Cancer. 2005 ; Vol. 5, No. 4. pp. 274-278.
@article{ff98fae3147549aaabb9257ff1b07fdc,
title = "Clinicopathologic significance of synchronous and metachronous adenomas in colorectal cancer",
abstract = "Purpose: Colorectal cancers (CRCs) evolve from a multiple-step tumorigenesis and, morphologically, are characterized by adenoma. Colorectal cancers with adenomas have distinct clinical features, including reports of improved survival. It is hypothesized that this survival advantage is related to biologic differences in CRC with adenomas rather than earlier diagnosis or earlier stage of disease presentation. Patients and Methods: A retrospective chart review of 569 patients treated from 1983 through 2002 was conducted. Data on age, sex, and survival; CRC stage, location, and recurrence; adenoma number, size, histology, and location; and colonoscopy history were analyzed. Results: The mean patient age was 62 years (range, 17-90 years), and 54{\%} of patients were men. The majority of CRCs were left-sided (67{\%}). The American Joint Committee on Cancer stage distribution was 0/I (12{\%}), II (21{\%}), III (34{\%}), and IV (33{\%}). Colorectal cancer with synchronous adenoma was seen in 33{\%} of cases; overall, CRC with adenoma comprised 42{\%} of cases. The event-free survival and overall survival favored CRC with adenoma. After adjusting for age, disease stage, sex, and total number of colonoscopic examinations, the relative risk for an event was 1.51 (P < 0.003) for patients without adenomas versus those with adenomas. Conclusion: Colorectal cancer with adenoma represents a distinct population of patients with CRC. The apparent association seems to confer a survival advantage that is not based on age, sex, or disease stage. The survival benefit, although slightly less dramatic, remained significant even when controlled for the number of colonoscopies.",
keywords = "Colonoscopy, Disease staging, Event-free survival, Familial adenopolyposis, Microsatellite instability",
author = "Mark Mattar and Paul Frankel and Donald David and Clarke, {Kevin O.} and Chu, {David Z.J.} and Chungling Jiang and Yun Yen",
year = "2005",
month = "1",
day = "1",
doi = "10.3816/CCC.2005.n.039",
language = "English",
volume = "5",
pages = "274--278",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Clinicopathologic significance of synchronous and metachronous adenomas in colorectal cancer

AU - Mattar, Mark

AU - Frankel, Paul

AU - David, Donald

AU - Clarke, Kevin O.

AU - Chu, David Z.J.

AU - Jiang, Chungling

AU - Yen, Yun

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Purpose: Colorectal cancers (CRCs) evolve from a multiple-step tumorigenesis and, morphologically, are characterized by adenoma. Colorectal cancers with adenomas have distinct clinical features, including reports of improved survival. It is hypothesized that this survival advantage is related to biologic differences in CRC with adenomas rather than earlier diagnosis or earlier stage of disease presentation. Patients and Methods: A retrospective chart review of 569 patients treated from 1983 through 2002 was conducted. Data on age, sex, and survival; CRC stage, location, and recurrence; adenoma number, size, histology, and location; and colonoscopy history were analyzed. Results: The mean patient age was 62 years (range, 17-90 years), and 54% of patients were men. The majority of CRCs were left-sided (67%). The American Joint Committee on Cancer stage distribution was 0/I (12%), II (21%), III (34%), and IV (33%). Colorectal cancer with synchronous adenoma was seen in 33% of cases; overall, CRC with adenoma comprised 42% of cases. The event-free survival and overall survival favored CRC with adenoma. After adjusting for age, disease stage, sex, and total number of colonoscopic examinations, the relative risk for an event was 1.51 (P < 0.003) for patients without adenomas versus those with adenomas. Conclusion: Colorectal cancer with adenoma represents a distinct population of patients with CRC. The apparent association seems to confer a survival advantage that is not based on age, sex, or disease stage. The survival benefit, although slightly less dramatic, remained significant even when controlled for the number of colonoscopies.

AB - Purpose: Colorectal cancers (CRCs) evolve from a multiple-step tumorigenesis and, morphologically, are characterized by adenoma. Colorectal cancers with adenomas have distinct clinical features, including reports of improved survival. It is hypothesized that this survival advantage is related to biologic differences in CRC with adenomas rather than earlier diagnosis or earlier stage of disease presentation. Patients and Methods: A retrospective chart review of 569 patients treated from 1983 through 2002 was conducted. Data on age, sex, and survival; CRC stage, location, and recurrence; adenoma number, size, histology, and location; and colonoscopy history were analyzed. Results: The mean patient age was 62 years (range, 17-90 years), and 54% of patients were men. The majority of CRCs were left-sided (67%). The American Joint Committee on Cancer stage distribution was 0/I (12%), II (21%), III (34%), and IV (33%). Colorectal cancer with synchronous adenoma was seen in 33% of cases; overall, CRC with adenoma comprised 42% of cases. The event-free survival and overall survival favored CRC with adenoma. After adjusting for age, disease stage, sex, and total number of colonoscopic examinations, the relative risk for an event was 1.51 (P < 0.003) for patients without adenomas versus those with adenomas. Conclusion: Colorectal cancer with adenoma represents a distinct population of patients with CRC. The apparent association seems to confer a survival advantage that is not based on age, sex, or disease stage. The survival benefit, although slightly less dramatic, remained significant even when controlled for the number of colonoscopies.

KW - Colonoscopy

KW - Disease staging

KW - Event-free survival

KW - Familial adenopolyposis

KW - Microsatellite instability

UR - http://www.scopus.com/inward/record.url?scp=33644843274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644843274&partnerID=8YFLogxK

U2 - 10.3816/CCC.2005.n.039

DO - 10.3816/CCC.2005.n.039

M3 - Article

C2 - 16356305

AN - SCOPUS:33644843274

VL - 5

SP - 274

EP - 278

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 4

ER -